Avalere Data Showing MTM Underused Could Inform Expansion Efforts

Avalere Health urges policymakers looking to expand the scope of the Medicare medication therapy management program to factor in new data showing that less than half of Medicare Part D beneficiaries eligible for MTM actually receive those services. An official with a medication-adherence coalition suggests the Avalere data underscore the group's concerns that CMS might not be targeting beneficiaries who could most benefit from the program. CMS had looked at expanding MTM to an additional 15.5 million beneficiaries as part...